Company
Verve Therapeutics
- Biotech
Description
Single-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
Verve Therapeutics is located in the Boston ecosystem.
Related
CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
Esperion Therapeutics ($ESPR)Develops and commercializes medicines for cardiovascular disease, including cholesterol management, cardiovascular risk reduction, and…
Mammoth BiosciencesDevelops in vivo gene-editing therapeutics, engineers CRISPR-Cas systems and editing strategies, and provides CRISPR-based detection…
Intellia Therapeutics ($NTLA)Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited…
Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
BioNTechBioNTech develops investigational therapies for cancer and infectious diseases, including mRNA cancer immunotherapies, immunomodulators,…
Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
Albany Medical CollegePrivate medical school and academic medical center in Albany, NY.
Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases…
Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
Colossal BiosciencesDevelops CRISPR-based genomics software tools and genetic engineering programs for de-extinction, including work on woolly mammoths using…
Scribe TherapeuticsEngineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and…